|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1998-12-23
|
|
pubmed:abstractText |
The long-term effect of recombinant human erythropoietin (rhEPO) on the blood-lipid profile has not been well documented. The aim of this study was to evaluate whether rhEPO therapy affects the lipid pattern.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2345-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9761520-Adult,
pubmed-meshheading:9761520-Aged,
pubmed-meshheading:9761520-Aged, 80 and over,
pubmed-meshheading:9761520-Apolipoprotein A-I,
pubmed-meshheading:9761520-Erythropoietin,
pubmed-meshheading:9761520-Female,
pubmed-meshheading:9761520-Hematocrit,
pubmed-meshheading:9761520-Hemoglobins,
pubmed-meshheading:9761520-Humans,
pubmed-meshheading:9761520-Injections, Intravenous,
pubmed-meshheading:9761520-Lipids,
pubmed-meshheading:9761520-Male,
pubmed-meshheading:9761520-Middle Aged,
pubmed-meshheading:9761520-Recombinant Proteins,
pubmed-meshheading:9761520-Renal Dialysis
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Lipid profile in haemodialysis patients treated with recombinant human erythropoietin.
|
|
pubmed:affiliation |
Department of Nephrology, Hospital de Santa Maria, Lisboa, Portugal.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|
